Patents by Inventor James Birchall

James Birchall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270985
    Abstract: The invention concerns a device for introducing microneedles into the skin of a subject; and a method for inserting microneedles into the skin of a subject comprising use of said device.
    Type: Application
    Filed: July 1, 2021
    Publication date: August 31, 2023
    Applicant: University College Cardiff Consultants Limited
    Inventors: James Birchall, Sion Coulman, Benedetta Gualeni, Oliver Bishop, Nicholas Smart, Isabelle Stauber
  • Patent number: 10232159
    Abstract: The invention relates to a device for use in skin improvement or repair, including promoting hair growth, comprising the use of microneedles for the transplantation of cells and a method employing the use of same.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: March 19, 2019
    Assignee: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: James Birchall, Sion Coulman, Dev Shah, Benedetta Gualeni
  • Patent number: 9895466
    Abstract: The invention relates to a novel antibiotic delivery vehicle for impregnating bone cement wherein said vehicle is an antibiotic encapsulated liposome having a block co-polymer on its surface; a method for the manufacture of a bone cement impregnated with antibiotic or a mixture of antibiotics using said vehicle; and also a novel bone cement made therewith and/or thereby.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: February 20, 2018
    Assignee: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Stephen Denyer, Samuel Evans, Wayne Ayre, James Birchall
  • Patent number: 8041421
    Abstract: A system for intradermal or transdermal delivery of oligonucleotides or polynucleotides and methods of use thereof employ an apparatus that generates micro-channels in the skin of a subject in conjunction with a pharmaceutical composition comprising an oligonucleotide or polynucleotide, wherein the oligonucleotide or polynucleotide can be delivered into the organism through the micro-channels. The system and methods achieve expression of target proteins encoded by the polynucleotides, and hence are useful in immunization and gene therapy.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: October 18, 2011
    Assignee: TransPharma Medical Ltd.
    Inventors: James Birchall, Galit Levin, Amikam Gershonowitz
  • Publication number: 20080114281
    Abstract: The present invention relates to a system for intradermal or transdermal delivery of oligonucleotides or polynucleotides and to methods of use thereof. Particularly, the present invention relates to a system comprising an apparatus that generates micro-channels in the skin of a subject in conjunction with a pharmaceutical composition comprising an oligonucleotide or polynucleotide, wherein the oligonucleotide or polynucleotide can be delivered into the organism through the micro-channels. The system and methods of the present invention achieve expression of target proteins encoded by the polynucleotides, and hence are useful in immunization and gene therapy.
    Type: Application
    Filed: January 25, 2005
    Publication date: May 15, 2008
    Applicant: TRANSPHARMA MEDICAL LTD.
    Inventors: James Birchall, Galit Levin, Amikam Gershonowitz
  • Patent number: 7207047
    Abstract: An operating system has a top level exception handler which terminates an application as a default action upon receipt of any exceptions. An application recovery system traps an exception which is dispatched to the top level exception handler before it reaches the top level exception handler. In the event, an exception cannot be resolved, the application recovery system terminates a thread that caused the exception, and continues execution of the application.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: April 17, 2007
    Assignee: Corel Corporation
    Inventors: Ramesh Subramanian, James Birchall, Andrew Van Beek
  • Publication number: 20030018681
    Abstract: An operating system has a top level exception handler which terminates an application as a default action upon receipt of any exceptions. An application recovery system traps an exception which is dispatched to the top level exception handler before it reaches the top level exception handler. In the event, an exception cannot be resolved, the application recovery system terminates a thread that caused the exception, and continues execution of the application.
    Type: Application
    Filed: July 11, 2001
    Publication date: January 23, 2003
    Applicant: Corel Corporation
    Inventors: Ramesh Subramanian, James Birchall, Andrew Van Beek